|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy of rituximab in gastric diffuse large B cell lymphoma patients显示文摘AIM:To evaluate retrospectively the efficacy of rituximab plus chemotherapy in gastric diffuse large B cell lymphoma(DLBCL).METHODS:Sixty patients(median age:58 years)with histologically confirmed gastric DLBCL treated at four Italian institutions between 2000 and 2007,were included in this analysis.Patients were selected by stage (Ⅰ-Ⅳ,Lugano staging system),European Cooperative Oncology Group performance status(0-2)and treatment strategies.Treatment strategies were chemotherapy alone(group A,n=30)[scheduled as cyclophosphamide,doxorubicin,vincristine and prednisone (CHOP)and CHOP-like],and chemotherapy combined with rituximab(group B,n=30).The primary end point of the study was complete response(CR)rate;the secondary end points were disease-free survival (DFS)at 5 years and overall survival(OS).RESULTS:Median follow-up was 62 mo(range:31102 mo).We observed a significant difference between the two groups(A vs B)in terms of CR[76.6%(23/30) vs 100%,P=0.04)and DFS at 5 years[73.3%(22/30) vs 100%,P=0.03).To date,19 group A(63.3%) patients are alive and 11 have died,while all group B patients are alive.No significant differences in toxicity were observed between the two groups.CONCLUSION:Rituximab in combination with chemotherapy improves CR rate,DFS and OS.Further prospective trials are needed to confirm our results. | Davide Leopardo Giuseppe Di Lorenzo Amalia De Renzo Piera Federico Serena Luponio Carlo Buonerba Elide Matano Gerardina Merola Martina Imbimbo Enzo Montesarchio Antonio Rea Maria Carmela Merola Sabino De Placido Giovannella Palmieri | 2010 | World Journal of Gastroenterology2010，16，20： | 19 |
| 2 | NMR and NQR studies on transition-metal arsenide superconductors LaRu2As2,KCa2Fe4As4F2,and A2Cr3As3显示文摘We report 75As-nuclear magnetic resonance(NMR)and nuclear quadrupole resonance(NQR)measurements on transition-metal arsenides LaRu2As2,KCa2Fe4As4F2,and A2Cr3As3.In the superconducting state of LaRu2As2,a Hebel–Slichter coherence peak is found in the temperature dependence of the spin-lattice relaxation rate 1/T1 just below Tc,which indicates that LaRu2As2 is a full-gap superperconducor.For KCa2Fe4As4F2,antiferromagnetic spin fluctuations are observed in the normal state.We further find that the anisotropy rate RAF=Tc 1/Tab 1 is small and temperature independent,implying that the low energy spin fluctuations are isotropic in spin space.Our results indicate that KCa2Fe4As4F2 is a moderately overdoped iron-arsenide high-temperature superconductor with a stoichiometric composition.For A2Cr3As3(A=Na,K,Rb,Cs),we calculate the electric field gradient by first-principle method and assign the 75As-NQR peaks to two crystallographically different As sites,paving the way for further NMR investigation. | 罗军 王春光 王志成 郭琦 杨杰 周睿 K Matano T Oguchi 任治安 曹光旱 郑国庆 | 2020 | Chinese Physics B2020，29，6： | 2 |
| 3 | A phase Ⅱ study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid as first line treatment advanced or metastatic gastric cancer patients显示文摘 | De Vita F Orditura M Matano E | 2005 | Br J Cancer2005，92，9： | 1 |
| 4 | Electron-do- nating perylene tetracarboxylic acids for dye-sensitized solar cells显示文摘 | Shibano Y Umeyama T Matano Y | 2007 | Org Lett2007，9，10： | 1 |
| 5 | Risk of colorectal neoplasm in patients with acromegaly and its relationship with serum growth hormone levels 显示文摘 | Matano Y Okada T Suzuki A | 2005 | Am J Gastroenterol2005，100，5： | 1 |
| 6 | Vacuum-assisted closure device enhances recovery of critically ill patients following emergency surgical procedures显示文摘 | Batacchi S Matano S Nella A | 2009 | Crit Care2009，13，6： | 1 |
| 7 | A phase Ⅱ study of bi- weekly oxaliplatin plus ilffusional 5-fluorouracil and folin-icacid (FOLFOX-4) as first-line treatment of advanced gastriccancerpa- tients显示文摘 | De Vita F Orditura M Matano E | 2005 | Br J Cancer2005，92，： | 1 |
| 8 | A phase Ⅱ study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid(FOLFOX-4)as first-line treatment of advanced gastric cancer patients显示文摘 | de Vita F Orditura M Matano E | 2005 | Br J Cancer2005，92，9： | 1 |
| 9 | Periodic trave-ling waves in a two - dimensional cylinder with saw -toothed boundary and their homogenization limit 显示文摘 | MATANO H NAKAMURA K LOU B | 2006 | Netw Heterog Media2006，1，4： | 1 |
| 10 | A phase II study of bi weekly oxaliplat in plus in fusional 5-fluorouracil and folinicacid(FOLFOX-4) as first-line treatment of advanced gastric cancer patients 显示文摘 | De Vita F Orditura M Matano E | 2005 | Br J Cancer2005，92，9： | 1 |
| 11 | A phase Ⅱ study of bi-weekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOL FOX4) as first-line treatment of advanced gastric cancer patients 显示文摘 | De Vita F Orditura M Matano E | 2005 | Br J Cancer2005，92，9： | 1 |
| 12 | A phase Ⅱ study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients 显示文摘 | de Vita F Orditura M Matano E | 2005 | Br J Cancer2005，92，： | 1 |
| 13 | A phase Ⅱ study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients显示文摘 | De Vita F Orditura M Matano E | 2005 | Br J Cancer2005，92，9： | 1 |
| 14 | A phase Ⅱ study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid(FOLFOX4) as first-line treatment of advanced gastric cancer patients显示文摘 | Vita FD Orditura M Matano E | | 0，，09： | 1 |
| 15 | A phase II study of biweek- ly oxaliplatin plus infusional 5 -fluorouracil and folinic acid (FOL- FOX -4 ) as first - line treatment of advanced gastric cancer patients显示文摘 | De Vita F Orditura M Matano E | 2005 | Br J Cancer2005，92，9： | 1 |
| 16 | A phase Ⅱ study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid(FOLFOX-4) as first-line treatment of advanced gastric cancer patients 显示文摘 | De Vita F Orditura M Matano E | 2005 | Br J Cancer2005，92，9： | 1 |
| 17 | Oxidative catalytic cracking of n-Butane to lower alkenes over layered BiOClcatalyst显示文摘 | Kijima N Matano K Saito M | 2001 | Appl Catal A2001，206，2： | 1 |
| 18 | A phase Ⅱ study of biweekly oxalipatin plus infusional 5-fluorouracil and folinic acid ( FOLFOX ~ 4 ) as first-line treatment of advanced gastric cancer patients 显示文摘 | De Vita F Orditura M Matano E | 2005 | Br J Cancer2005，92，9： | 1 |
| 19 | A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinicacid (FOLFOX-4) as first-line treatment of ad- vanced gastric cancer patients显示文摘 | De Vita F Orditura M Matano E | 2005 | Br J Cancer2005，92，9： | 1 |
| 20 | A phase Ⅱ study of biweekly oxaliplatin plus infusion 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients显示文摘 | Ordituda M Matano E | 2005 | Br J Cancer2005，92，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员